You have 9 free searches left this month | for more free features.

Hydroxyurea,

Showing 26 - 50 of 441

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

HIV Trial (Indinavir sulfate, Ritonavir, Hydroxyurea)

Withdrawn
  • HIV Infections
  • Indinavir sulfate
  • +4 more
  • (no location specified)
Oct 28, 2021

Sickle Cell Disease Trial in Ibadan, Kano, Lagos (Etavopivat, Hydroxyurea)

Recruiting
  • Sickle Cell Disease
  • Ibadan, Nigeria
  • +2 more
Jul 12, 2023

Sickle Cell Anemia, Children, Only Trial in United States (Hydroxyurea SDM Toolkit, Clinician Pocket Guide)

Recruiting
  • Sickle Cell Anemia
  • Children, Only
  • Hydroxyurea SDM Toolkit
  • Clinician Pocket Guide
  • Oakland, California
  • +10 more
Feb 9, 2022

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

Recruiting
  • Sickle Cell Disease
  • Sickle Cell Anemia
  • Chart Review
  • Survey
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 8, 2021

HIV Trial (Tetanus Toxoid Vaccine, Hydroxyurea, Didanosine)

Withdrawn
  • HIV Infections
  • Tetanus Toxoid Vaccine
  • +2 more
  • (no location specified)
Oct 28, 2021

Sickle Cell Disease Trial in Memphis (hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and

Recruiting
  • Sickle Cell Disease
  • hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus
  • hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
May 5, 2022

Sickle Cell Disease Trial in United States (HABIT Intervention)

Completed
  • Sickle Cell Disease
  • HABIT Intervention
  • Bronx, New York
  • +3 more
Mar 7, 2022

Sickle Cell Disease, Sickle Cell Anemia Trial in United States (Hydroxyurea)

Recruiting
  • Sickle Cell Disease
  • Sickle Cell Anemia
  • Phoenix, Arizona
  • +13 more
Dec 7, 2021

Identify and Describe Predictive Factors for Thromboembolic

Not yet recruiting
  • Polycythemia Vera
  • Hydroxyurea
  • Ruxolitinib
  • (no location specified)
Nov 2, 2022

Sickle Cell Disease, Renal Function Disorder Trial in Creteil (Siklos)

Completed
  • Sickle Cell Disease
  • Renal Function Disorder
  • Creteil, France
    Centre de Référence des Syndromes Drépanocytaires Majeurs, Hôpit
Sep 20, 2021

Priapism Due to Sickle Cell Disease Trial in Kano (Tadalafil, Hydroxyurea, Placebo)

Recruiting
  • Priapism Due to Sickle Cell Disease
  • Kano, Nigeria
  • +1 more
Aug 23, 2022

Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

Recruiting
  • Sickle Cell Disease
  • Bone Marrow Transplant (BMT)
  • +7 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Sep 13, 2022

Sickle Cell Disease Trial in Assiut (Hydroxycarbamide 500 Mg Oral Capsule+L-Carnitine, Hydroxycarbamide 500 Mg Oral Capsule,

Completed
  • Sickle Cell Disease
  • Hydroxycarbamide 500 Mg Oral Capsule+L-Carnitine
  • +2 more
  • Assiut, Egypt
    Safaa A A Khaled
Oct 15, 2021

Sickle Cell Disease, Stroke Trial in Kaduna (Hydroxyurea)

Recruiting
  • Sickle Cell Disease
  • Stroke
  • Kaduna, Nigeria
    Barau Dikko Teaching Hospital/Kaduna State University
Jun 24, 2022

HPV-Negative Squamous Cell Carcinoma Trial in Chicago (Paclitaxel, Carboplatin, Cetuximab)

Not yet recruiting
  • HPV-Negative Squamous Cell Carcinoma
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Aug 16, 2023

Sickle Cell Anemia Trial in Santo Domingo (Hydroxyurea, TCD examination)

Active, not recruiting
  • Sickle Cell Anemia
  • Santo Domingo, Dominican Republic
    Encargada del Servicio de Hematología-Oncología Hospital Infanti
Jan 17, 2023

Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

Recruiting
  • Sickle Cell Anemia
  • Beta Thalassemia
  • TBI
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Sickle Cell Anemia Trial in United States (Hydroxyurea)

Completed
  • Sickle Cell Anemia
  • Atlanta, Georgia
  • +3 more
Jun 3, 2021

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

Recruiting
  • Sickle Cell Disease
  • haploidentical stem cell transplant
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Stroke Prevention in Young Adults With Sickle Cell Anemia

Active, not recruiting
  • Sickle Cell Disease
  • +5 more
  • Hydroxyurea therapy per standard care
  • Nashville, Tennessee
  • +1 more
Jul 13, 2022

Thalassemia Trial in Peshawar (Thalidomide and Hydroxyurea)

Completed
  • Thalassemia
  • Thalidomide and Hydroxyurea
  • Peshawar, Khyber Pakhtukhwa, Pakistan
    Blood Diseases Clinic
Mar 10, 2022

HIV Trial in United States (Hydroxyurea, Didanosine)

Completed
  • HIV Infections
  • San Diego, California
  • +17 more
Oct 28, 2021

Brain and CNS Tumors Trial in France (hydroxyurea)

Completed
  • Brain and Central Nervous System Tumors
  • Bordeaux, France
  • +4 more
Feb 19, 2021

Polycythemia Vera Trial in Worldwide (Idasanutlin)

Terminated
  • Polycythemia Vera
  • Phoenix, Arizona
  • +10 more
Dec 7, 2021